Recent evidence indicates the elasticity of AML cells in modulating CD8+ T cell responses and the plasticity of their signatures upon chemotherapy response, which is capable of reversing some dysfunctional features of BM-infiltrating T cells [42]. This evidence concerns the gene CD8A and acute myeloid leukemia.